Express Pharma

Morepen Labs clocks double-digit growth in its sales and net profit in FY 2019-20

Consolidated Profit before Tax (PBT) recorded extraordinary growth by 34 per cent at Rs. 39.11 crore, up from Rs. 29.18 crore in the previous fiscal

0 2,657